INSIGHTS ON DRUG DEVELOPMENT
-
![CRISPR Meets LNPs: A New Era In Cell And Gene Therapies]( "CRISPR Meets LNPs: A New Era In Cell And Gene Therapies")
CRISPR Meets LNPs: A New Era In Cell And Gene TherapiesExplore how lipid nanoparticles are revolutionizing non-viral gene editing with scalable, efficient delivery for both ex vivo and in vivo applications, which features new CRISPR-LNP data in T cells.
-
![GettyImages-1306663245-intestinal-organoid-scientist]( "Evaluating Compound Toxicity Effects On Healthy Intestinal Organoids")
Evaluating Compound Toxicity Effects On Healthy Intestinal Organoids3D organoids enhance drug toxicity prediction and are crucial for anti-cancer drug development. Examine a method using 3D mouse intestinal organoids that aims to provide vital data on intestinal toxicity.
-
![Female researcher analyzing scientific samples-GettyImages-2231025177]( "Organ-On-A-Chip Technology Unlocks Patient-Derived Precision Medicine")
Organ-On-A-Chip Technology Unlocks Patient-Derived Precision MedicinePersonalized medicine struggles with models that fail to reflect real human biology. Organ-on-a-Chip systems recreate tissue complexity, helping predict patient-specific treatment responses.
-
![assessing ta webinar thumb]( "Assessing Production And Stability Of Antibody Drug Conjugate Platforms")
Assessing Production And Stability Of Antibody Drug Conjugate PlatformsADCs with similar antibody sequences can behave differently due to linker and payload choices. Analytical tools reveal structural and stability differences critical to therapeutic performance.
-
Inside Bioprocessing: Continuous Perfusion11/4/2025
Learn about the essential elements of upstream workflows, media optimization strategies, and liquid handling logistics required to implement continuous perfusion successfully.
-
Modifying The Micro-Environment To Improve Dissolution Rate6/11/2025
Discover how modifying the micro-environment with targeted excipients can significantly enhance the dissolution rate of poorly soluble drugs using conventional manufacturing methods.
-
Improve The Performance Of Your Small And Large Molecule Medicines7/23/2024
Explore the latest in nanotechnology advancements including recent clinical data, formulation applications, and API optimization to NanoImprove formulations.
-
Optimize Your RNA-LNP Delivery With Ionizable Lipids4/3/2025
Ionizable lipids play a crucial role in optimizing LNP delivery. Discover how lipid nanoparticles revolutionize intracellular drug delivery to enhance RNA vaccines, cell therapies, protein replacement, and gene editing.
-
A Fast And Simple ddPCR Assay For In-Depth AAV Characterization4/1/2026
Achieve precise AAV characterization with a streamlined digital assay. This video illustrates a rapid, four-step workflow that delivers accurate empty-to-full ratios in under eight hours.
DRUG DEVELOPMENT SOLUTIONS
-
![leica-microsystems-m165-fc-her]( "Fluorescent Stereo Microscope - Leica M165 FC")
Fluorescent Stereo Microscope Leica M165 FC
The Leica M165 FC fully apochromatic corrected stereo microscope with 16.5:1 zoom optics resolves structures down to 1.1 micron for detailed fluorescent imaging.
Image coding allows easy, convenient reproduction of image settings and parameters for fast, consistent, high quality observation and documentation.
TripleBeam technology dedicates a separate beam channel for fluorescence illumination to enhance image contrast, details and intensity for better performance.
-
![GettyImages-1187680243-biological-indicator-sterilization]( "Sterile Drug Product")
Accelerate sterile injectable development with expert support, advanced facilities, and tailored solutions for complex APIs — from formulation through commercialization across small molecules and biologics.
-
![Nanoform]( "Controlled Expansion Of Supercritical Solutions (CESS®) Technology")
Nanoform’s award-winning Controlled Expansion of Supercritical Solutions (CESS®) technology is a bottom-up nanoparticle engineering approach that enables the creation of API nanoparticles and can unlock the full therapeutic potential of small molecule drugs.
-
![Waters ACQUITY Premier Column Family]( "MaxPeak Premier Columns For Peptide Analysis")
MaxPeak™ Premier Columns utilize MaxPeak High Performance Surfaces that are designed to increase analyte recovery, sensitivity, and reproducibility by minimizing analyte/surface interactions that can lead to sample losses.
-
![Structure Elucidator Suite™]( "Elucidate Complex Structures From Real Data")
Characterize the Best-Fit Structure for Your NMR and MS Data
ACD/Structure Elucidator Suite is the industry-leading software solution for computer-assisted structure elucidation (CASE). It offers a reliable workflow and accurate results for de novo elucidation of complex organic compound structures.
Use Structure Elucidator Suite to:
- Determine structures using NMR and other analytical data
- Generate all the candidate structures that fit your NMR and MS data
- Rank the generated structures and identify the most probable one
- Determine 3D configuration from a 2D structure using NOESY/ROESY data
- Dereplicate previously identified compounds
- Search fragment databases or manually define fragments for partially known structures
- Report the final structure and add SDFiles to the prediction databases
